Structures by: Cho S.
Total: 33
C9H10NO3P
C9H10NO3P
Organic letters (2014) 16, 11 3098-3101
a=6.8770(14)Å b=16.165(3)Å c=8.6840(17)Å
α=90.00° β=107.06(3)° γ=90.00°
C10H12NO3P
C10H12NO3P
Organic letters (2014) 16, 11 3098-3101
a=7.2030(14)Å b=8.5010(17)Å c=17.051(3)Å
α=90.00° β=90.90(3)° γ=90.00°
C21H24Cl2FeN4O10
C21H24Cl2FeN4O10
Chem.Commun. (2012) 48, 5449
a=11.3781(2)Å b=18.5161(3)Å c=12.4123(2)Å
α=90.00° β=91.2170(10)° γ=90.00°
C96H144ClMnN14O28Zn2
C96H144ClMnN14O28Zn2
Chemical Communications (2006) 24
a=15.1376(18)Å b=15.2092(18)Å c=26.300(3)Å
α=73.271(2)° β=77.508(2)° γ=82.596(2)°
<i>N</i>-dichlorofluoromethylthio-<i>N</i>',<i>N</i>'-dimethyl-<i>N</i>-<i>p</i>-tolylsulfamide
C10H13Cl2FN2O2S2
Acta Crystallographica Section E (2014) 70, 10 o1114-o1115
a=23.7638(19)Å b=8.7046(7)Å c=14.6559(11)Å
α=90.00° β=102.133(3)° γ=90.00°
3,6-bis(2-Chlorophenyl)-1,2,4,5-tetrazine
C14H8Cl2N4
Acta Crystallographica Section E (2014) 70, 10 o1135
a=3.8199(4)Å b=14.0706(16)Å c=12.1066(15)Å
α=90.00° β=97.715(3)° γ=90.00°
4-Cyclopropyl-6-methyl-<i>N</i>-phenylpyrimidin-2-amine
C14H15N3
Acta Crystallographica Section E (2015) 71, 1 o5
a=13.1920(6)Å b=5.3176(2)Å c=16.8641(7)Å
α=90.00° β=100.288(2)° γ=90.00°
1-{3,5-Dichloro-4-[3-chloro-5-(trifluoromethyl)pyridin-2-yloxy]phenyl}-3-(2,6-difluorobenzoyl)urea
C20H9Cl3F5N3O3
Acta Crystallographica Section E (2015) 71, 1 o55
a=8.5805(3)Å b=10.1281(4)Å c=12.5883(4)Å
α=79.498(2)° β=82.930(2)° γ=83.485(2)°
<i>catena</i>-Poly[[silver(I)-<i>μ</i>-<i>N</i>-(pyridin-2-ylmethyl)\ pyridine-3-amine-κ^2^<i>N</i>:<i>N</i>] trifluoromethanesulfonate]
C11H11AgN3,CF3O3S
Acta Crystallographica Section E (2014) 70, 11 389-391
a=13.7529(6)Å b=10.8437(5)Å c=19.5795(9)Å
α=90.00° β=99.8260(10)° γ=90.00°
1-({2-[2-Chloro-4-(4-chlorophenoxy)phenyl]-4-methyl-1,3-dioxolan-2-yl}methyl)-1<i>H</i>-1,2,4-triazole
C19H17Cl2N3O3
Acta Crystallographica Section E (2014) 70, 11 o1173
a=25.6913(13)Å b=10.0220(4)Å c=14.6417(6)Å
α=90.00° β=93.439(4)° γ=90.00°
Triclopyr
C7H4Cl3NO3
Acta Crystallographica Section E (2014) 70, 9 o940
a=7.5771(9)Å b=25.409(3)Å c=10.1668(12)Å
α=90.00° β=106.261(8)° γ=90.00°
Vinclozolin
C12H9Cl2NO3
Acta Crystallographica Section E (2014) 70, 7 o754
a=15.0727(12)Å b=5.2947(5)Å c=15.5390(12)Å
α=90.00° β=100.916(5)° γ=90.00°
Diafenthiuron
C23H32N2OS
Acta Crystallographica Section E (2014) 70, 7 o807
a=12.8656(2)Å b=17.9807(3)Å c=10.1671(2)Å
α=90.00° β=102.6550(10)° γ=90.00°
<i>N</i>,<i>N</i>-diethyl-2-(naphthalen-1-yloxy)propanamide
C17H21NO2
Acta Crystallographica Section E (2013) 69, 8 o1207
a=9.8733(3)Å b=10.7710(4)Å c=14.1044(5)Å
α=90.00° β=97.943(2)° γ=90.00°
Bifenox
C14H9Cl2NO5
Acta Crystallographica Section E (2013) 69, 8 o1206
a=8.4945(7)Å b=9.9610(8)Å c=10.3969(8)Å
α=64.6010(10)° β=68.7200(10)° γ=70.4210(10)°
KJB-IV-287
C19H25N3O4
Journal of the American Chemical Society (2017) 139, 33 11622-11628
a=11.3187(3)Å b=12.1229(3)Å c=14.6266(4)Å
α=85.2769(14)° β=75.3317(14)° γ=75.7870(14)°
C36H54B20O2P2Rh2S2
C36H54B20O2P2Rh2S2
Organometallics (2002) 21, 1 210-219
a=14.633(2)Å b=30.160(2)Å c=10.8636(9)Å
α=90.00° β=92.414(9)° γ=90.00°
C21H35B10OP2RhS
C21H35B10OP2RhS
Organometallics (2002) 21, 1 210-219
a=11.6078(6)Å b=21.9130(10)Å c=11.6386(8)Å
α=90.00° β=96.846(5)° γ=90.00°
C22H32B10IrPS
C22H32B10IrPS
Organometallics (2002) 21, 1 210-219
a=12.6869(10)Å b=11.1010(6)Å c=18.7413(10)Å
α=90.00° β=99.366(6)° γ=90.00°
C22H32B10IrPS
C22H32B10IrPS
Organometallics (2002) 21, 1 210-219
a=12.6869(10)Å b=11.1010(6)Å c=18.7413(10)Å
α=90.00° β=99.366(6)° γ=90.00°
C48H76B20O6P2Rh2S2
C48H76B20O6P2Rh2S2
Organometallics (2002) 21, 1 210-219
a=14.7620(7)Å b=16.5850(7)Å c=25.9780(7)Å
α=90.00° β=92.688(2)° γ=90.00°
C22H32B10PRhS
C22H32B10PRhS
Organometallics (2002) 21, 1 210-219
a=12.6713(13)Å b=11.114(2)Å c=18.743(3)Å
α=90.00° β=99.061(11)° γ=90.00°
C30H40B20Ir2O2P2S2
C30H40B20Ir2O2P2S2
Organometallics (2002) 21, 1 210-219
a=14.8970(14)Å b=29.9518(17)Å c=10.8565(8)Å
α=90.00° β=92.945(7)° γ=90.00°
C74H16F30N8,C14O,C7
C74H16F30N8,C14O,C7
Journal of the American Chemical Society (2009) 131, 6412-6420
a=28.63(3)Å b=6.521(7)Å c=40.62(4)Å
α=90.00° β=92.241(18)° γ=90.00°
C88H30Cl8F30N8
C88H30Cl8F30N8
Journal of the American Chemical Society (2009) 131, 6412-6420
a=45.961(17)Å b=6.915(3)Å c=28.648(14)Å
α=90.00° β=115.291(14)° γ=90.00°
C100H69Cl3F30N8O2Zn2
C100H69Cl3F30N8O2Zn2
Journal of the American Chemical Society (2009) 131, 6412-6420
a=14.9948(4)Å b=39.4282(8)Å c=16.3092(4)Å
α=90.00° β=109.6514(11)° γ=90.00°
C76H58F20N6Si2
C76H58F20N6Si2
Journal of the American Chemical Society (2009) 131, 7360-7367
a=16.210(4)Å b=20.391(5)Å c=23.229(6)Å
α=90.00° β=98.095(12)° γ=90.00°
N-Benzyl-3,7-dimethylimidazo[1,2-a]pyridine-2-carboxamide
C17H17N3O
Bioorganic & Medicinal Chemistry Letters (2014) 24, 3493-3498
a=7.9379(3)Å b=19.6844(9)Å c=9.5568(4)Å
α=90.° β=100.934(2)° γ=90.°
N-Benzyl-7-methyl-[1,2,4]triazolo[4,3-a]pyridine-3-carboxamide
C15H14N4O
Bioorganic & Medicinal Chemistry Letters (2014) 24, 3493-3498
a=9.772(3)Å b=5.8461(19)Å c=22.078(7)Å
α=90.° β=91.411(6)° γ=90.°
N-Benzyl-5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidine-2-carboxamide
C15H15N5O
Bioorganic & Medicinal Chemistry Letters (2014) 24, 3493-3498
a=20.3189(11)Å b=10.8268(5)Å c=15.6023(9)Å
α=90.° β=129.107(3)° γ=90.°
N-Benzyl-6-methyl-2H-indazole-3-carboxamide
C16H15N3O
Bioorganic & Medicinal Chemistry Letters (2014) 24, 3493-3498
a=5.9164(2)Å b=13.0740(3)Å c=18.5711(5)Å
α=109.4990(10)° β=93.229(2)° γ=94.402(2)°
N-Benzyl-2,6-dimethylimidazo[1,2-b]pyridazine-3-carboxamide
C16H16N4O
Bioorganic & Medicinal Chemistry Letters (2014) 24, 3493-3498
a=9.3005(8)Å b=6.6121(5)Å c=11.8267(10)Å
α=90.° β=106.2760(10)° γ=90.°
N-Benzyl-2,7-dimethylimidazo[1,2-a]pyridine-3-carboxamide (1)
C17H17N3O
Bioorganic & Medicinal Chemistry Letters (2014) 24, 3493-3498
a=4.8686(4)Å b=15.1351(13)Å c=19.0283(18)Å
α=94.372(5)° β=93.841(6)° γ=93.639(5)°